Sartorius Stedim Biotech annual gross margin
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Gross Margin Growth & History (DIM)
Sartorius Stedim Biotech's gross margin was 45.33% for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 45.33% | +1.93 pp |
| 2024 | 2024-12-31 | 43.41% | −1.05 pp |
| 2023 | 2023-12-31 | 44.46% | −7.57 pp |
| 2022 | 2022-12-31 | 52.03% | −1.76 pp |
| 2021 | 2021-12-31 | 53.79% | +1.27 pp |
| 2020 | 2020-12-31 | 52.53% | — |
Sartorius Stedim Biotech gross margin trends
Over the last five fiscal years, Sartorius Stedim Biotech's gross margin decreased from 52.53% to 45.33%, a change of −7.19 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗